Form 8-K - Current report:
SEC Accession No. 0001193125-08-216152
Filing Date
2008-10-24
Accepted
2008-10-24 16:54:12
Documents
1
Period of Report
2008-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 12293
  Complete submission text file 0001193125-08-216152.txt   13877
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 081140563
SIC: 2836 Biological Products, (No Diagnostic Substances)